Evidence is labelled on each development below (company-reported, regulatory filing or government record), not on the company as a whole. Coverage is not an offer to invest. Private ownership does not imply available shares. Next scheduled recheck: Nov 27, 2026.
Timeline
- Sep 28, 2026 · Private financing (Form D)
Precision Neuroscience reports $250 million of securities sold in a private offering
Regulatory filing
Profile
- Legal name
- Precision Neuroscience Corp
- SEC filer
- CIK 0001858288 ↗
- Incorporated
- DE
- Coverage
- Offering notices + any filings + federal awards
Mix of developments
Watch Precision Neuroscience
Anything new from Precision Neuroscience lands in your digest, with the source beside it. Following is about information, never an investment action. Up to 10 companies or frontiers on Pro, $49/month.
Follow this companyPreview a sample digestPrivate offerings reported to the SEC (Form D)
A Form D is a notice a company files after selling securities without a public registration. Amount sold is cumulative for that offering as reported by the company; an amendment (D/A) updates an earlier notice, so rows are not added together. None of these is a valuation or an open offer.
| Filed | Form | Amount sold | Offering size | First sale | Investors | Exemption | Record |
|---|---|---|---|---|---|---|---|
| Sep 28, 2026 | D | $250 million | No fixed total | Sep 11, 2026 | 46 | Rule 506(b) | SEC ↗ |
| Oct 17, 2024 | D | $93.1 million | $150 million | Oct 2, 2024 | 21 | Rule 506(b) | SEC ↗ |
| Apr 2, 2024 | D | $27.5 million | $45.0 million | Mar 26, 2024 | 5 | Rule 506(b) | SEC ↗ |
| Feb 1, 2023 | D/A | $41.2 million | $42.0 million | Dec 5, 2022 | 20 | Rule 506(b) | SEC ↗ |
| Dec 19, 2022 | D | $34.3 million | $45.0 million | Dec 5, 2022 | 15 | Rule 506(b) | SEC ↗ |
| Apr 28, 2021 | D | $10.5 million | $12.0 million | Apr 16, 2021 | 2 | Rule 506(b) | SEC ↗ |